MSB & MVP LIKELY TO BE 2 MAJOR BIOTECH SHARES IN ASX

Highlights:

• ASX: MSB & ASX: MVP likely to follow CSL’s example
• Biotechnology in Australia is showing immense potential akin to mines and banks

CSL Limited (ASX: CSL) was recently announced to be the world's third most successful biotech business. At the beginning of the year, the CSL share price split into 300 dollars per action barrier and is about to become the mos....